W;t Read online




  The author and publisher have provided this e-book to you for your personal use only. You may not make this e-book publicly available in any way. Copyright infringement is against the law. If you believe the copy of this e-book you are reading infringes on the author’s copyright, please notify the publisher at: us.macmillanusa.com/piracy.

  Contents

  Title Page

  Copyright Notice

  Acknowledgments

  Characters

  Notes

  Begin Reading

  Critical Acclaim for W;t

  About the Author

  Copyright

  This text is based on the production of Wit that opened at the Union Square Theatre, New York City, on January 7, 1999. It was produced by MCC Theater, Long Wharf Theatre, and Daryl Roth, with Stanley Shopkorn, Robert G. Bartner, and Stanley Kaufelt; associate producer, Lorie Cowen Levy. General management by Roy Gabay. The production was directed by Derek Anson Jones. The set was designed by Myung Hee Cho; the costume design was by Ilona Somogyi; the lighting design was by Michael Chybowski; the music and sound design were by David Van Tieghem; the wigs were by Paul Huntley. The production manager was Kai Brothers. The production stage manager was Katherine Lee Boyer. The casting was by Bernard Telsey Casting.

  The cast was as follows:

  VIVIAN BEARING, PH.D.

  Kathleen Chalfant

  HARVEY KELEKIAN, M.D./MR. BEARING

  Walter Charles

  JASON POSNER, M.D.

  Alec Phoenix

  SUSIE MONAHAN, R.N., B.S.N.

  Paula Pizzi

  E. M. ASHFORD, D.PHIL.

  Helen Stenborg

  LAB TECHNICIANS/STUDENTS/RESIDENTS

  Brian J. Carter, Daniel Sarnelli, Alli Steinberg, Lisa Tharps

  The production opened originally at the Long Wharf Theatre, New Haven, Connecticut, on October 31, 1997. Doug Hughes, artistic director; Michael Ross, managing director.

  It opened in New York at MCC Theater, September 17, 1998. Robert LuPone and Bernard Telsey, executive directors; William Cantler, associate director.

  Wit was first performed at the South Coast Repertory Theater in Costa Mesa, California, on January 24, 1995. It was produced by South Coast Repertory, David Emmes, producing artistic director, and Martin Benson, artistic director. The production was directed by Martin Benson. The set was designed by Cliff Faulkner; the costume design was by Kay Peebles; the lighting design was by Paulie Jenkins; the music and sound design were by Michael Roth. The production manager was Michael Mora. The stage manager was Randall K. Lum.

  The cast was as follows:

  VIVIAN BEARING, PH.D.

  Megan Cole

  HARVEY KELEKIAN, M.D./MR. BEARING

  Richard Doyle

  JASON POSNER, M.D.

  Brian Drillinger

  SUSIE MONAHAN, R.N., B.S.N.

  Mary Kay Wulf

  E. M. ASHFORD, D.PHIL.

  Patricia Fraser

  LAB TECHNICIANS/STUDENTS/RESIDENTS

  Christopher DuVal, Kyle Jones, Stacy L. Porter

  ACKNOWLEDGMENTS

  Thanks to the cast that read the first draft of Wit in July 1991: Joyce Edson, Derek Anson Jones, Michael Edson, Leslie Spitz-Edson, and Calvin Gidney. Thanks to Mary and Steve Ales and the late Ruth Mortimer for reading the next draft. Thanks to Jerry Patch, Martin Benson, and my friends at South Coast Repertory. Thanks to Doug Hughes and my friends at Long Wharf Theatre, and Bernard Telsey and my friends at MCC. Thanks to Carolyn French and my friends at the Fifi Oscard Agency. Thanks to Linda Merrill for hearing every word.

  CHARACTERS

  VIVIAN BEARING, PH.D.

  50; professor of seventeenth-century poetry at the university

  HARVEY KELEKIAN, M.D.

  50; chief of medical oncology, University Hospital

  JASON POSNER, M.D.

  28; clinical fellow, Medical Oncology Branch

  SUSIE MONAHAN, R.N., B.S.N.

  28; primary nurse, Cancer Inpatient Unit

  E. M. ASHFORD, D.PHIL.

  80; professor emerita of English literature

  MR. BEARING

  Vivian’s father

  LAB TECHNICIANS

  CLINICAL FELLOWS

  STUDENTS

  CODE TEAM

  The play may be performed with a cast of nine: the four TECHNICIANS, FELLOWS, STUDENTS, and CODE TEAM MEMBERS should double; DR. KELEKIAN and MR. BEARING should double.

  NOTES

  Most of the action, but not all, takes place in a room of the University Hospital Comprehensive Cancer Center. The stage is empty, and furniture is rolled on and off by the technicians.

  Jason and Kelekian wear lab coats, but each has a different shirt and tie every time he enters. Susie wears white jeans, white sneakers, and a different blouse each entrance.

  Scenes are indicated by a line rule in the script; there is no break in the action between scenes, but there might be a change in lighting. There is no intermission.

  Vivian has a central-venous-access catheter over her left breast, so the IV tubing goes there, not into her arm. The IV pole, with a Port-a-Pump attached, rolls easily on wheels. Every time the IV pole reappears, it has a different configuration of bottles.

  (VIVIAN BEARING walks on the empty stage pushing her IV pole. She is fifty, tall and very thin, barefoot, and completely bald. She wears two hospital gowns—one tied in the front and one tied in the back—a baseball cap, and a hospital ID bracelet. The house lights are at half strength. VIVIAN looks out at the audience, sizing them up.)

  VIVIAN: (In false familiarity, waving and nodding to the audience) Hi. How are you feeling today? Great. That’s just great. (In her own professorial tone) This is not my standard greeting, I assure you.

  I tend toward something a little more formal, a little less inquisitive, such as, say, “Hello.”

  But it is the standard greeting here.

  There is some debate as to the correct response to this salutation. Should one reply “I feel good,” using “feel” as a copulative to link the subject, “I,” to its subjective complement, “good”; or “I feel well,” modifying with an adverb the subject’s state of being?

  I don’t know. I am a professor of seventeenth-century poetry, specializing in the Holy Sonnets of John Donne.

  So I just say, “Fine.”

  Of course it is not very often that I do feel fine.

  I have been asked “How are you feeling today?” while I was throwing up into a plastic washbasin. I have been asked as I was emerging from a four-hour operation with a tube in every orifice, “How are you feeling today?”

  I am waiting for the moment when someone asks me this question and I am dead.

  I’m a little sorry I’ll miss that.

  It is unfortunate that this remarkable line of inquiry has come to me so late in my career. I could have exploited its feigned solicitude to great advantage: as I was distributing the final examination to the graduate course in seventeenth-century textual criticism—“Hi. How are you feeling today?”

  Of course I would not be wearing this costume at the time, so the question’s ironic significance would not be fully apparent.

  As I trust it is now.

  Irony is a literary device that will necessarily be deployed to great effect.

  I ardently wish this were not so. I would prefer that a play about me be cast in the mythic-heroic-pastoral mode; but the facts, most notably stage-four metastatic ovarian cancer, conspire against that. The Faerie Queene this is not.

  And I was dismayed to discover that the play would contain elements of … humor.

  I have been, at best, an unwitting accomplice. (She pauses.) It is not my intention to give away the plot; but I think I die at the end.

  They’ve given me less than two hours.
/>
  If I were poetically inclined, I might employ a threadbare metaphor—the sands of time slipping through the hourglass, the two-hour glass.

  Now our sands are almost run;

  More a little, and then dumb.

  Shakespeare. I trust the name is familiar.

  At the moment, however, I am disinclined to poetry.

  I’ve got less than two hours. Then: curtain.

  (She disconnects herself from the IV pole and shoves it to a crossing TECHNICIAN. The house lights go out.)

  * * *

  VIVIAN: I’ll never forget the time I found out I had cancer.

  (DR. HARVEY KELEKIAN enters at a big desk piled high with papers.)

  KELEKIAN: You have cancer.

  VIVIAN: (To audience) See? Unforgettable. It was something of a shock. I had to sit down. (She plops down.)

  KELEKIAN: Please sit down. Miss Bearing, you have advanced metastatic ovarian cancer.

  VIVIAN: Go on.

  KELEKIAN: You are a professor, Miss Bearing.

  VIVIAN: Like yourself, Dr. Kelekian.

  KELEKIAN: Well, yes. Now then. You present with a growth that, unfortunately, went undetected in stages one, two, and three. Now it is an insidious adenocarcinoma, which has spread from the primary adnexal mass—

  VIVIAN: “Insidious”?

  KELEKIAN: “Insidious” means undetectable at an—

  VIVIAN: “Insidious” means treacherous.

  KELEKIAN: Shall I continue?

  VIVIAN: By all means.

  KELEKIAN: Good. In invasive epithelial carcinoma, the most effective treatment modality is a chemotherapeutic agent. We are developing an experimental combination of drugs designed for primary-site ovarian, with a target specificity of stage three-and-beyond administration.

  VIVIAN: Insidious. Hmm. Curious word choice. Cancer. Cancel.

  “By cancer nature’s changing course untrimmed.” No—that’s not it.

  Am I going too fast?

  (To KELEKIAN) No.

  Good.

  You will be hospitalized as an in-patient for treatment each cycle. You will be on complete intake-and-output measurement for three days after each treatment to monitor kidney function. After the initial eight cycles, you will have another battery of tests.

  Must read something about cancer.

  Must get some books, articles. Assemble a bibliography.

  Is anyone doing research on cancer?

  Concentrate.

  The antineoplastic will inevitably affect some healthy cells, including those lining the gastrointestinal tract from the lips to the anus, and the hair follicles. We will of course be relying on your resolve to withstand some of the more pernicious side effects.

  Antineoplastic. Anti: against. Neo: new. Plastic. To mold. Shaping. Antineoplastic. Against new shaping.

  Hair follicles. My resolve.

  “Pernicious” That doesn’t seem—

  KELEKIAN: Miss Bearing?

  VIVIAN: I beg your pardon?

  KELEKIAN: Do you have any questions so far?

  VIVIAN: Please, go on.

  KELEKIAN: Perhaps some of these terms are new. I realize—

  VIVIAN: No, no. Ah. You’re being very thorough.

  KELEKIAN: I make a point of it. And I always emphasize it with my students—

  VIVIAN: So do I. “Thoroughness”—I always tell my students, but they are constitutionally averse to painstaking work.

  KELEKIAN: Yours, too.

  VIVIAN: Oh, it’s worse every year.

  KELEKIAN: And this is not dermatology, it’s medical oncology, for Chrissake.

  VIVIAN: My students read through a text once—once!—and think it’s time for a break.

  KELEKIAN: Mine are blind.

  VIVIAN: Well, mine are deaf.

  KELEKIAN: (Resigned, but warmly) You just have to hope …

  VIVIAN: (Not so sure) I suppose.

  (Pause)

  KELEKIAN: Where were we, Dr. Bearing?

  VIVIAN: I believe I was being thoroughly diagnosed.

  KELEKIAN: Right. Now. The tumor is spreading very quickly, and this treatment is very aggressive. So far, so good?

  VIVIAN: Yes.

  KELEKIAN: Better not teach next semester.

  VIVIAN: (Indignant) Out of the question.

  KELEKIAN: The first week of each cycle you’ll be hospitalized for chemotherapy; the next week you may feel a little tired; the next two weeks’ll be fine, relatively. This cycle will repeat eight times, as I said before.

  VIVIAN: Eight months like that?

  KELEKIAN: This treatment is the strongest thing we have to offer you. And, as research, it will make a significant contribution to our knowledge.

  VIVIAN: Knowledge, yes.

  KELEKIAN: (Giving her a piece of paper) Here is the informed-consent form. Should you agree, you sign there, at the bottom. Is there a family member you want me to explain this to?

  VIVIAN: (Signing) That won’t be necessary.

  KELEKIAN: (Taking back the paper) Good. The important thing is for you to take the full dose of chemotherapy. There may be times when you’ll wish for a lesser dose, due to the side effects. But we’ve got to go full-force. The experimental phase has got to have the maximum dose to be of any use. Dr. Bearing—

  VIVIAN: Yes?

  KELEKIAN: You must be very tough. Do you think you can be very tough?

  VIVIAN: You needn’t worry.

  KELEKIAN: Good. Excellent.

  (KELEKIAN and the desk exit as VIVIAN stands and walks forward.)

  VIVIAN: (Hesitantly) I should have asked more questions, because I know there’s going to be a test.

  I have cancer, insidious cancer, with pernicious side effects—no, the treatment has pernicious side effects.

  I have stage-four metastatic ovarian cancer. There is no stage five. Oh, and I have to be very tough. It appears to be a matter, as the saying goes, of life and death.

  I know all about life and death. I am, after all, a scholar of Donne’s Holy Sonnets, which explore mortality in greater depth than any other body of work in the English language.

  And I know for a fact that I am tough. A demanding professor. Uncompromising. Never one to turn from a challenge. That is why I chose, while a student of the great E. M. Ashford, to study Donne.

  (PROFESSOR E. M. ASHFORD, fifty-two, enters, seated at the same desk as KELEKIAN was. The scene is twenty-eight years ago. VIVIAN suddenly turns twenty-two, eager and intimidated.)

  VIVIAN: Professor Ashford?

  E.M.: Do it again.

  VIVIAN: (To audience) It was something of a shock. I had to sit down. (She plops down.)

  E.M.: Please sit down. Your essay on Holy Sonnet Six, Miss Bearing, is a melodrama, with a veneer of scholarship unworthy of you—to say nothing of Donne. Do it again.

  VIVIAN: I, ah …

  E.M.: You must begin with a text, Miss Bearing, not with a feeling.

  Death be not proud, though some have called thee Mighty and dreadfull, for, thou art not soe.

  You have entirely missed the point of the poem, because, I must tell you, you have used an edition of the text that is inauthentically punctuated. In the Gardner edition—

  VIVIAN: That edition was checked out of the library—

  E.M.: Miss Bearing!

  VIVIAN: Sorry.

  E.M.: You take this too lightly, Miss Bearing. This is Metaphysical Poetry, not The Modern Novel. The standards of scholarship and critical reading which one would apply to any other text are simply insufficient. The effort must be total for the results to be meaningful. Do you think the punctuation of the last line of this sonnet is merely an insignificant detail?

  The sonnet begins with a valiant struggle with death, calling on all the forces of intellect and drama to vanquish the enemy. But it is ultimately about overcoming the seemingly insuperable barriers separating life, death, and eternal life.

  In the edition you chose, this profoundly simple meaning is sacrificed to hysterical punctuation:<
br />
  And Death—capital D—shall be no more—semicolon!

  Death—capital D—comma—thou shalt die—exclamation point!

  If you go in for this sort of thing, I suggest you take up Shakespeare.

  Gardner’s edition of the Holy Sonnets returns to the Westmoreland manuscript source of 1610—not for sentimental reasons, I assure you, but because Helen Gardner is a scholar. It reads:

  And death shall be no more, comma, Death thou shalt die.

  (As she recites this line, she makes a little gesture at the comma.)

  Nothing but a breath—a comma—separates life from life everlasting. It is very simple really. With the original punctuation restored, death is no longer something to act out on a stage, with exclamation points. It’s a comma, a pause.

  This way, the uncompromising way, one learns something from this poem, wouldn’t you say? Life, death. Soul, God. Past, present. Not insuperable barriers, not semicolons, just a comma.

  VIVIAN: Life, death … I see. (Standing) It’s a metaphysical conceit. It’s wit! I’ll go back to the library and rewrite the paper—

  E.M.: (Standing, emphatically) It is not wit, Miss Bearing. It is truth. (Walking around the desk to her) The paper’s not the point.

  VIVIAN: It isn’t?

  E.M.: (Tenderly) Vivian. You’re a bright young woman. Use your intelligence. Don’t go back to the library. Go out. Enjoy yourself with your friends. Hmm?

  (VIVIAN walks away. E.M. slides off.)

  VIVIAN: (As she gradually returns to the hospital) I, ah, went outside. The sun was very bright. I, ah, walked around, past the … There were students on the lawn, talking about nothing, laughing. The insuperable barrier between one thing and another is … just a comma? Simple human truth, uncompromising scholarly standards? They’re connected? I just couldn’t …

  I went back to the library.

  Anyway.

  All right. Significant contribution to knowledge.

  Eight cycles of chemotherapy. Give me the full dose, the full dose every time.